0001012975-17-000819.txt : 20171113
0001012975-17-000819.hdr.sgml : 20171110
20171113095618
ACCESSION NUMBER: 0001012975-17-000819
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170930
FILED AS OF DATE: 20171113
DATE AS OF CHANGE: 20171113
EFFECTIVENESS DATE: 20171113
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clarus Ventures, LLC
CENTRAL INDEX KEY: 0001431431
IRS NUMBER: 202234539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16028
FILM NUMBER: 171193765
BUSINESS ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-2200
MAIL ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001431431
XXXXXXXX
09-30-2017
09-30-2017
Clarus Ventures, LLC
101 MAIN STREET
SUITE 1210
CAMBRIDGE
MA
02142
13F HOLDINGS REPORT
028-16028
N
Robert W. Liptak
Managing Director
617-949-2200
/s/ Robert W. Liptak
Cambridge
MA
11-13-2017
0
5
122849
false
INFORMATION TABLE
2
ClarusQ317.xml
VBI Vaccines Inc.
COM
91822J103
10360
2691042
SH
DFND
2691042
0
0
Sientra Inc.
COM
82621J105
42054
2730765
SH
DFND
2730765
0
0
Nanostring Technologies Inc.
COM
63009R109
63985
3959440
SH
DFND
3959440
0
0
Catabasis Pharmaceuticals Inc.
COM
14875P107
5835
2752488
SH
DFND
2752488
0
0
ESSA Pharma Inc.
COM
29668H104
615
2121212
SH
DFND
2121212
0
0